• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

143
19
13
13
11

COUNTRY

5
4
4
4
3

PRICE

86
119
288
511

PUBLISHED

1
16
130
511

PRODUCT TYPE

505
3
2
1

Immune Disorders

(511 Products)

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

Global Neurodegenerative Diseases Market 2015-2019

About neurodegenerative diseases According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech,...

May 2015
FROM

Immunoassay Systems - Global Strategic Business Report

This report analyzes the worldwide markets for Immunoassay Systems in US$ Million by the following Product Segments, which includes Immunoassay Analyzers and Reagents: Enzyme Immunoassay Systems, Fluorescence...

September 2014
FROM

Immune Checkpoint Inhibitors Market, 2014 - 2024

Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues to...

November 2014
FROM

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

November 2014
FROM
EpiCast Report: Myasthenia Gravis - Epidemiology Forecast to 2024 EpiCast Report: Myasthenia Gravis - Epidemiology Forecast to 2024 - Product Thumbnail Image

EpiCast Report: Myasthenia Gravis - Epidemiology Forecast to 2024

EpiCast Report: Myasthenia Gravis - Epidemiology Forecast to 2024 Summary Myasthenia gravis is an autoimmune disease that affects the nerves and muscles and is characterized by muscle weakness and...

June 2015
FROM
Therapy Class Overview : Hepatitis C Virus Infection Therapy Class Overview : Hepatitis C Virus Infection - Product Thumbnail Image

Therapy Class Overview : Hepatitis C Virus Infection

Freedom from injecting Interferon (IFN), treating major HCV genotypes WW and betting on vaccines could bring a sea of change in the treatment of HCV infection in the future This year the first IFN-free...

October 2013
FROM
Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape - Product Thumbnail Image

Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Summary "Gene Therapy Immunology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles...

July 2015
FROM

Hypersensitivity - Pipeline Review, H1 2015

Hypersensitivity - Pipeline Review, H1 2015 Summary This, ‘Hypersensitivity - Pipeline Review, H1 2015’, provides an overview of the Hypersensitivity’s therapeutic pipeline. This report provides...

May 2015
FROM

Cedar Pollen Allergy - Pipeline Review, H1 2015

Cedar Pollen Allergy - Pipeline Review, H1 2015 Summary This, ‘Cedar Pollen Allergy - Pipeline Review, H1 2015’, provides an overview of the Cedar Pollen Allergy’s therapeutic pipeline. This report...

May 2015
FROM

Sjogren's Syndrome - Pipeline Review, H1 2015

Sjogren's Syndrome - Pipeline Review, H1 2015 Summary This, ‘Sjogren's Syndrome - Pipeline Review, H1 2015’, provides an overview of the Sjogren's Syndrome’s therapeutic pipeline. This report provides...

May 2015
FROM

Wegener's Granulomatosis - Pipeline Review, H1 2015

Wegener's Granulomatosis - Pipeline Review, H1 2015 Summary The‘Wegener's Granulomatosis - Pipeline Review, H1 2015’, provides an overview of the Wegener's Granulomatosis’s therapeutic pipeline. This...

May 2015
FROM

AutoImmune Drug Focus Issue

This first approved generic glatiramer acetate has been a long time coming, but the hesitancy in launching shows that the battle to produce a generic Copaxone is not yet over. FDA approval will nonetheless...

May 2015

Disease & Therapy Review (DTR) Executive Market Summaries

Disease & Therapy Review is meant to be an accurate and efficient executive synopsis of the indications that IPD users look up most frequently Each report includes epidemiology from the IPD (Incidence...

May 2015

Lupus Nephritis - Pipeline Review, H1 2015

Lupus Nephritis - Pipeline Review, H1 2015 Summary This, ‘Lupus Nephritis - Pipeline Review, H1 2015’, provides an overview of the Lupus Nephritis’s therapeutic pipeline. This report provides comprehensive...

April 2015
FROM

Severe Psoriasis - Pipeline Review, H1 2015

Severe Psoriasis - Pipeline Review, H1 2015 Summary This, ‘Severe Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Severe Psoriasis’s therapeutic pipeline. This report provides...

April 2015
FROM

Moderate Psoriasis - Pipeline Review, H1 2015

Moderate Psoriasis - Pipeline Review, H1 2015 Summary This, ‘Moderate Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Moderate Psoriasis’s therapeutic pipeline. This report provides...

April 2015
FROM

Peanut Allergy - Pipeline Review, H1 2015

Peanut Allergy - Pipeline Review, H1 2015 Summary The report titled ‘Peanut Allergy - Pipeline Review, H1 2015’ provides an overview of the Peanut Allergy’s therapeutic pipeline. This report...

April 2015
FROM

Mild Psoriasis - Pipeline Review, H1 2015

Mild Psoriasis - Pipeline Review, H1 2015 Summary This, ‘Mild Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Mild Psoriasis’s therapeutic pipeline. This report provides comprehensive...

April 2015
FROM

Liver Transplantation - Pipeline Review, H1 2015

Liver Transplantation - Pipeline Review, H1 2015 Summary This, ‘Liver Transplantation - Pipeline Review, H1 2015’, provides an overview of the Liver Transplantation’s therapeutic pipeline. This report...

April 2015
FROM

Heart Transplantation - Pipeline Review, H1 2015

Heart Transplantation - Pipeline Review, H1 2015 Summary This, ‘Heart Transplantation - Pipeline Review, H1 2015’, provides an overview of the Heart Transplantation’s therapeutic pipeline. This report...

April 2015
FROM
Loading Indicator

Our Clients

Merck & Co., Inc. Celgene Corporation GlaxoSmithKline PLC Genentech, Inc. Johnson & Johnson Services, Inc. ViiV Healthcare